336 related articles for article (PubMed ID: 12790691)
1. Current management strategies for coexisting diabetes mellitus and obesity.
Scheen AJ
Drugs; 2003; 63(12):1165-84. PubMed ID: 12790691
[TBL] [Abstract][Full Text] [Related]
2. Treatment of diabetes in patients with severe obesity.
Scheen AJ
Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
5. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
Scheen AJ; Ernest P
Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
Scheen AJ
Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
[TBL] [Abstract][Full Text] [Related]
9. [Obesity and type 2 diabetes].
Rorive M; Letiexhe MR; Scheen AJ; Ziegler O
Rev Med Liege; 2005; 60(5-6):374-82. PubMed ID: 16035297
[TBL] [Abstract][Full Text] [Related]
10. The management of the obese diabetic patient.
Albu J; Raja-Khan N
Prim Care; 2003 Jun; 30(2):465-91. PubMed ID: 14567159
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatment of the obese diabetic patient.
Scheen AJ; Lefebvre PJ
Diabete Metab; 1993; 19(6):547-59. PubMed ID: 8026606
[TBL] [Abstract][Full Text] [Related]
12. Management of blood glucose in type 2 diabetes mellitus.
Ripsin CM; Kang H; Urban RJ
Am Fam Physician; 2009 Jan; 79(1):29-36. PubMed ID: 19145963
[TBL] [Abstract][Full Text] [Related]
13. The impact of pharmacotherapy on weight management in type 2 diabetes.
Hauner H
Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S12-7. PubMed ID: 10455466
[TBL] [Abstract][Full Text] [Related]
14. Obesity medications and the treatment of type 2 diabetes.
Greenway F
Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
[TBL] [Abstract][Full Text] [Related]
15. Management of non-insulin-dependent diabetes mellitus.
Lefèbvre PJ; Scheen AJ
Drugs; 1992; 44 Suppl 3():29-38. PubMed ID: 1280575
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM; Raskin P
Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
[TBL] [Abstract][Full Text] [Related]
17. Recent developments and emerging therapies for type 2 diabetes mellitus.
Evans AJ; Krentz AJ
Drugs R D; 1999 Aug; 2(2):75-94. PubMed ID: 10820647
[TBL] [Abstract][Full Text] [Related]
18. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Wolffenbuttel BH; van Haeften TW
Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
[TBL] [Abstract][Full Text] [Related]
19. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
Cheah JS
Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
[TBL] [Abstract][Full Text] [Related]
20. Diabesity: therapeutic options.
Colagiuri S
Diabetes Obes Metab; 2010 Jun; 12(6):463-73. PubMed ID: 20518802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
